Eleni Korompoki

Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

Long COVID: major findings, mechanisms and recommendations

Unexplained post-acute infection syndromes

Abnormal quantitative pupillary light responses following COVID-19

Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation

Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months

SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors

Pupillometry in critically ill patients with COVID-19: a prospective study

Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review

Late‐onset hematological complications post COVID‐19: An emerging medical problem for the hematologist

Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine